Mesothelioma Cancer Resources Blog

Source: Cytopia Limited Cytopia Limited, a privately-held biotechnology firm from Australia, has recently announced that its anti-cancer drug CYT997 has begun a Phase II clinical trial for the treatment of relapsed or refractory multiple myeloma. Cytopia also announced that along with an upcoming Phase II clinical trial for the treatment of glioblastoma multiforme, they are …

Source: Industrial Health 2007, 45, 787-792 As awareness of the hazards of asbestos exposure became more common during the last few decades, many developed nations implemented statutory protocols strictly regulating the manner in which asbestos could be commercially used. Some of these nations even moved past regulation and enacted outright bans on the use of …

p>Clinical Trial Phase: Phase 2 Start Date: June 2005 Overall Status: Recruiting Estimated Enrollment: 53 Rationale Condition Keyword(s): Mesothelioma Interventions: Drug: pemetrexed Drug: cisplatin   Phase II trial of Neoadjuvant Chemotherapy with Pemetrexed plus Cisplatin followed by Surgery and Radiotherapy in patients with Malignant Pleural Mesothelioma stage I-III. The event-free survival is the primary endpoint …